IOL Chemicals and Pharmaceuticals Limited
13 Aug 2026
-
Hello. Hi sir. Thanks for the opportunity. Hello
Read in transcript -
Yes. So, sir, my first question is that export contribution increased to around like 28.5% of revenue from like from 24.4% Y -o-Y. So, like, do you see this moving towards 30% plus of revenue in the near terms or would you prefer to maintain a more balanced domestic export mix?
Read in transcript -
Yes, sir. Yes, sir. And my next question is that, like, with Q1 EBITDA margin at 14.6%, like ahead of the FY27 guidance range of 14% to 15%, so what are the key factors that could either sustain the margin above this range or lead to moderation in the coming quarters?
Read in transcript